» Articles » PMID: 19819943

Free Fatty Acids Induce a Proinflammatory Response in Islets Via the Abundantly Expressed Interleukin-1 Receptor I

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2009 Oct 13
PMID 19819943
Citations 154
Authors
Affiliations
Soon will be listed here.
Abstract

Islets of patients with type 2 diabetes mellitus (T2DM) display features of an inflammatory process including elevated levels of the cytokine IL-1beta, various chemokines, and macrophages. IL-1beta is a master regulator of inflammation, and IL-1 receptor type I (IL-1RI) blockage improves glycemia and insulin secretion in humans with T2DM and in high-fat-fed mice pointing to a pivotal role of IL-1RI activity in intra-islet inflammation. Given the association of dyslipidemia and T2DM, we tested whether free fatty acids (FFA) promote the expression of proinflammatory factors in human and mouse islets and investigated a role for the IL-1RI in this response. A comparison of 22 mouse tissues revealed the highest IL-1RI expression levels in islets and MIN6 beta-cells. FFA induced IL-1beta, IL-6, and IL-8 in human islets and IL-1beta and KC in mouse islets. Elevated glucose concentrations enhanced FFA-induced proinflammatory factors in human islets. Blocking the IL-1RI with the IL-1R antagonist (IL-1Ra) strongly inhibited FFA-mediated expression of proinflammatory factors in human and mouse islets. Antibody inhibition of IL-1beta revealed that FFA stimulated IL-1RI activity via the induction of the receptor ligand. FFA-induced IL-1beta and KC expression in mouse islets was completely dependent on the IL-1R/Toll-like receptor (TLR) docking protein Myd88 and partly dependent on TLR2 and -4. Activation of TLR2 in purified human beta-cells and islets stimulated the expression of proinflammatory factors, and IL-1RI activity increased the TLR2 response in human islets. We conclude that FFA and TLR stimulation induce proinflammatory factors in islets and that IL-1RI engagement results in signal amplification.

Citing Articles

Unraveling the role of macrophages in diabetes: Impaired phagocytic function and therapeutic prospects.

Rong B, Jiang H, Zhu W, Yang G, Zhou X, Lyu Z Medicine (Baltimore). 2025; 104(8):e41613.

PMID: 39993124 PMC: 11856964. DOI: 10.1097/MD.0000000000041613.


Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.


LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK.

Filipowska J, Cisneros Z, Varghese S, Leon-Rivera N, Wang P, Kang R Mol Metab. 2025; 92:102097.

PMID: 39788290 PMC: 11788739. DOI: 10.1016/j.molmet.2025.102097.


Gestational Diabetes Mellitus-Induced Inflammation in the Placenta via IL-1β and Toll-like Receptor Pathways.

Zgutka K, Tkacz M, Tomasiak P, Piotrowska K, Ustianowski P, Pawlik A Int J Mol Sci. 2024; 25(21).

PMID: 39518962 PMC: 11546908. DOI: 10.3390/ijms252111409.


The Therapeutic Potential of GLP-1 Receptor Agonists in the Management of Hidradenitis Suppurativa: A Systematic Review of Anti-Inflammatory and Metabolic Effects.

Krajewski P, Zlotowska A, Szepietowski J J Clin Med. 2024; 13(21).

PMID: 39518431 PMC: 11547001. DOI: 10.3390/jcm13216292.